SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (3336)12/16/1997 10:45:00 AM
From: JOHN W.  Read Replies (1) of 6136
 
The real reason Henry Niman has shown so much interest in AGPH after stating he had no financial motivation for his posts and was only trying to enlighten the board. I cried foul early. From todays article on LGND that mentions AGPH (why?):

"There is little buzz about any KS drugs among investors, since new AIDS drug cocktails have been saving and prolonging lives, leading to a dwindling of the incidence of the skin cancer. But as patients develop resistance to the new AIDS drug combinations, the incidence of KS could go up."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext